MedPath

重庆中创科医药有限公司

Ownership
-
Established
2007-05-24
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

5

NMPA:5

Drug Approvals

Hydrotalcite Suspension

Product Name
铝碳酸镁混悬液
Approval Number
国药准字H20254454
Approval Date
Jun 3, 2025
NMPA

Esomeprazole Sodium for Injection

Product Name
注射用艾司奥美拉唑钠
Approval Number
国药准字H20243180
Approval Date
Feb 6, 2024
NMPA

Ketorolac Trometamol Injection

Product Name
酮咯酸氨丁三醇注射液
Approval Number
国药准字H20234457
Approval Date
Dec 29, 2023
NMPA

Ketorolac Trometamol Injection

Product Name
酮咯酸氨丁三醇注射液
Approval Number
国药准字H20234458
Approval Date
Dec 29, 2023
NMPA

Acetylcysteine Solution for Inhalation

Product Name
吸入用乙酰半胱氨酸溶液
Approval Number
国药准字H20234753
Approval Date
Dec 29, 2023
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.